Related Experiment Video
Updated: Oct 8, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Microcephalic Osteodysplastic Primordial Dwarfism Type II With Associated Glucose-6-Phosphate Dehydrogenase
Fadi Busaleh1, Haider Alnofaily1, Hussain A Al Ghadeer1
1Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.
Abstract:
Microcephalic primordial dwarfism is a group of disorders that result in growth restriction and multiple morbidities. The condition is subdivided into three categories, with microcephalic osteodysplastic primordial dwarfism type II (MOPDII) being the most prevalent. Globally, only a few cases have been reported, with only available information about these disorders described in the literature. In this case report, we present the clinical findings seen in an infant with MOPDII in Saudi Arabia with associated glucose-6-phosphate dehydrogenase deficiency hemolytic anemia.
Insights
Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is a rare growth disorder. This case report details an infant with MOPDII and glucose-6-phosphate dehydrogenase deficiency anemia in Saudi Arabia.
Area of Science:
- Genetics and rare diseases
- Pediatric endocrinology
- Hematology
Background:
- Microcephalic primordial dwarfism encompasses rare genetic disorders characterized by severe growth restriction.
- Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is the most common subtype, yet remains exceptionally rare globally.
- Existing literature on MOPDII is limited, underscoring the importance of case reports.
Observation:
- This report describes a unique case of MOPDII in an infant residing in Saudi Arabia.
- The infant presented with characteristic features of MOPDII, including significant growth restriction.
- Notably, the infant also exhibited glucose-6-phosphate dehydrogenase deficiency, leading to hemolytic anemia.
Findings:
- The co-occurrence of MOPDII and glucose-6-phosphate dehydrogenase deficiency anemia in this infant is a significant clinical observation.
- This presentation expands the known clinical spectrum of MOPDII.
- The findings highlight the importance of comprehensive genetic and metabolic evaluations in patients with primordial dwarfism.
Implications:
- This case contributes valuable data to the limited global understanding of MOPDII.
- It emphasizes the need for increased awareness and reporting of rare genetic conditions in diverse geographical regions.
- Further research into the potential genetic or clinical links between MOPDII and G6PD deficiency is warranted.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Pedigree Analysis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...